|
TOP NEWS
Merck Loses HHS Suit Over Medicare Drug Price Program
By Jared Foretek
A D.C. federal judge shot down Merck's challenge to the Inflation Reduction Act's Drug Price Negotiation Program on Monday, ruling that the pharmaceutical giant's voluntary participation in connected Medicare and Medicaid programs meant that its inclusion in the negotiation program doesn't constitute an unconstitutional taking.
Order attached |
Read full article »
| Save to favorites »
LITIGATION
LEGAL INDUSTRY
|